 Home > Medical News > Latest Medical News > Xuantai Pharmaceutical Science and Technology Innovation Board IPO application accepted, plans to raise 600 million yuan

Xuantai Pharmaceutical Science and Technology Innovation Board IPO application accepted, plans to raise 600 million yuan

 Last Update: 2021-07-29
 Source: Internet
 Author: User

Tags

tiotropium capsules

buffer preparation

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On May 20, 2021, according to the Shanghai Stock Exchange, the listing committee meeting has accepted the listing application of Suntime Pharmaceutical

Plan for the use of raised funds:

Shanghai Xuantai Pharmaceutical Technology Co.

Focusing on the "insoluble drug solubilization technology platform", the company has established a target drug screening system, has a relatively comprehensive solubilization system design and application capabilities, and has mastered self-emulsification liquefaction, grinding method, solvent evaporation method, co-precipitation method, thermal Various solubilization preparation technologies such as melt extrusion method, fluidized bed spray method, solvent granulation method, etc.

The company's future development strategy will be based on the development trend of the global pharmaceutical industry, based on its own advantages, continue to deepen the high-end generic drugs and CRO business areas, and continue to expand its business into new areas such as improved new drugs to enhance its competitiveness

As of the signing date of this prospectus, the issuer’s share capital structure is as shown in the figure below:

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.